Singh G Dave, Kim Hee Nam
Institute of Craniofacial Sleep Medicine, Vivos Therapeutics, Inc., 9135 S Ridgeline Blvd Suite #100, Highlands Ranch, CO 80129, United States.
Star White Dental Clinic, South Korea.
World J Otorhinolaryngol Head Neck Surg. 2020 Oct 19;7(2):133-138. doi: 10.1016/j.wjorl.2020.07.007. eCollection 2021 Apr.
For the treatment of obstructive sleep apnea in adults, mandibular advancement devices (MADs) are often used. Since adults with a prognathic mandibular phenotype are at risk of developing an unfavorable facial profile, midfacial development using biomimetic oral appliance therapy might provide a suitable alternative. However, the effect of this procedure on the maxillary air sinuses is unknown; therefore, changes in sinus pneumatization were investigated in this study.
After obtaining informed consent, 16 consecutive Korean adults with midfacial hypoplasia had 3D cone-beam (CB) CT scans taken, and biomimetic upper appliances (DNA appliance®, Vivos Therapeutics, Inc., USA) were constructed.All subjects were instructed to wear the device 12-16 h/day. Each month, examination for the progress of midfacial development was recorded. Post-treatment, a follow-up 3D CBCT scan was undertaken with no device in the patient's mouth. Pre- and post-treatment linear and volumetric measurements were obtained using appropriate software, and compared statistically using -tests.
The mean age of the sample was 25.0 yrs ± 8.7. The mean treatment time was 15.5 mths ± 5.2. Post-treatment, the transpalatal bone width increased from 35.3 mm ± 3.0 to 38.5 mm ± 2.0 ( < 0.001); the maxillary air sinus volume on the left side increased from 18.8 cm ± 6.5 to 20.0 cm ± 6.0 ( < 0.05), and from 18.5 cm ± 5.7 to 19.7 cm ± 5.8 ( < 0.05) on the right side.
Biomimetic oral appliance therapy may be able to increase the maxillary air sinus volume in adults. In view of these preliminary findings, further studies on the effect of enhanced pneumatization on paranasal sinus function and sleep parameters are warranted.
对于成人阻塞性睡眠呼吸暂停的治疗,常使用下颌前移装置(MADs)。由于具有下颌前突表型的成年人有出现不良面部轮廓的风险,使用仿生口腔矫治器疗法促进面中部发育可能提供一种合适的替代方法。然而,该 procedure 对面上颌窦的影响尚不清楚;因此,本研究调查了鼻窦气化的变化。
在获得知情同意后,对16名连续的面中部发育不全的韩国成年人进行了3D锥形束(CB)CT扫描,并制作了仿生上颌矫治器(DNA矫治器®,Vivos Therapeutics公司,美国)。所有受试者均被指示每天佩戴该装置12 - 16小时。每月记录面中部发育进展的检查情况。治疗后,在患者口腔未佩戴装置的情况下进行随访3D CBCT扫描。使用适当软件获得治疗前后的线性和体积测量值,并使用t检验进行统计学比较。
样本的平均年龄为25.0岁±8.7岁。平均治疗时间为15.5个月±5.2个月。治疗后,腭骨宽度从35.3毫米±3.0增加到38.5毫米±2.0(P < 0.001);左侧上颌窦体积从18.8立方厘米±6.5增加到20.0立方厘米±6.0(P < 0.05),右侧从18.5立方厘米±5.7增加到19.7立方厘米±5.8(P < 0.05)。
仿生口腔矫治器疗法可能能够增加成人的上颌窦体积。鉴于这些初步发现,有必要进一步研究增强气化对鼻窦功能和睡眠参数的影响。